UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 2009
Impax Laboratories, Inc.
(Exact name of registrant as specified in its charter)
| | | | | |
| Delaware | | 000-27354 | | 65-0403311 |
| | | | | |
| (State or other jurisdiction | | (Commission | | (IRS Employer |
| of incorporation) | | File Number) | | Identification No.) |
| | | |
| 30831 Huntwood Avenue, Hayward, CA | | 94544 |
| | | |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code:(510) 476-2000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On February 26, 2009, Impax Laboratories, Inc. issued a press release announcing its results for the fourth quarter and fiscal year ended December 31, 2008. A copy of this press release is attached hereto asExhibit 99.1 and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
The following exhibit is filed herewith.
| | | | | |
| Exhibit No. | | Description |
| | 99.1 | | | Press release issued February 26, 2009. |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| Dated: February 26, 2009 | IMPAX LABORATORIES, INC.
| |
| | By: | /s/ Arthur A. Koch, Jr. | |
| | | Name: | Arthur A. Koch, Jr. | |
| | | Title: | Senior Vice President, Finance, and
Chief Financial Officer | |
2
EXHIBIT INDEX
| | | | | |
| Exhibit No. | | Description |
| | 99.1 | | | Press release issued February 26, 2009. |
3
